Brasky, Theodore M and Lampe, Johanna W and Slatore, Christopher G and White, Emily (2011) Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort. Cancer causes & control : CCC, 22 (9). pp. 1333-1342. ISSN 1573-7225
Preview |
Text (Complete manuscript)
BraskyTM_GC_and_Lung_Cancer.pdf Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (140kB) | Preview |
Abstract
Inflammation plays an important role in lung carcinogenesis. Epidemiologic studies have reported inverse associations of non-steroidal anti-inflammatory drug (NSAID) use and lung cancer risk. Previously, we found that ever use of glucosamine and chondroitin, which have anti-inflammatory properties, were inversely associated with lung cancer risk. After an additional year of follow-up, we further examined the association including frequency/duration of use, interaction with factors associated with inflammation, and lung cancer histology.
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | “The final publication is available at www.springerlink.com” |
| DOI: | 10.1007/s10552-011-9806-8 |
| PubMed ID: | 21706174 |
| PMCID: | PMC3175750 |
| Grant Numbers: | R25-CA94880,, and, R01-CA142545, K05-CA154337 |
| Depositing User: | Library Staff |
| Date Deposited: | 02 Sep 2011 23:15 |
| Last Modified: | 16 Sep 2015 07:17 |
| URI: | http://authors.fhcrc.org/id/eprint/497 |
Repository Administrators Only
 |
View Item |
